Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to -$62.8 million.

  • Kiniksa Pharmaceuticals International's Cash from Investing Activities fell 88857.91% to -$62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.9 million, marking a year-over-year decrease of 2439.37%. This contributed to the annual value of $37.7 million for FY2024, which is 22745.54% up from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Cash from Investing Activities stood at -$62.8 million, which was down 88857.91% from -$3.9 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Cash from Investing Activities ranged from a high of $86.0 million in Q2 2021 and a low of -$62.8 million during Q3 2025
  • Moreover, its 5-year median value for Cash from Investing Activities was -$6.3 million (2024), whereas its average is $552263.2.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 53838.46% in 2024, then plummeted by 88857.91% in 2025.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Cash from Investing Activities stood at -$50.0 million in 2021, then rose by 14.75% to -$42.7 million in 2022, then skyrocketed by 65.09% to -$14.9 million in 2023, then surged by 538.38% to $65.3 million in 2024, then plummeted by 196.11% to -$62.8 million in 2025.
  • Its Cash from Investing Activities stands at -$62.8 million for Q3 2025, versus -$3.9 million for Q2 2025 and -$51.5 million for Q1 2025.